These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15931265)

  • 1. Antiangiogenic treatment with endostatin inhibits progression of AML in vivo.
    Schuch G; Oliveira-Ferrer L; Loges S; Laack E; Bokemeyer C; Hossfeld DK; Fiedler W; Ergun S
    Leukemia; 2005 Aug; 19(8):1312-7. PubMed ID: 15931265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of angiogenesis selectively reduce the malignant cell load in rodent models of human myeloid leukemias.
    Iversen PO; Sorensen DR; Benestad HB
    Leukemia; 2002 Mar; 16(3):376-81. PubMed ID: 11896541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moderate antiangiogenic activity by local, transgenic expression of endostatin in Rip1Tag2 transgenic mice.
    Schaffhauser B; Veikkola T; Strittmatter K; Antoniadis H; Alitalo K; Christofori G
    J Leukoc Biol; 2006 Oct; 80(4):669-76. PubMed ID: 16793908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endostatin affects osteoblast behavior in vitro, but collagen XVIII/endostatin is not essential for skeletal development in vivo.
    Sipola A; Seppinen L; Pihlajaniemi T; Tuukkanen J
    Calcif Tissue Int; 2009 Nov; 85(5):412-20. PubMed ID: 19763371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the microenvironment in promoting angiogenesis in acute myeloid leukemia.
    Litwin C; Leong KG; Zapf R; Sutherland H; Naiman SC; Karsan A
    Am J Hematol; 2002 May; 70(1):22-30. PubMed ID: 11994978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model.
    Tanabe K; Maeshima Y; Ichinose K; Kitayama H; Takazawa Y; Hirokoshi K; Kinomura M; Sugiyama H; Makino H
    Kidney Int; 2007 Feb; 71(3):227-38. PubMed ID: 17191085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin.
    Zhang X; Xu J; Lawler J; Terwilliger E; Parangi S
    Clin Cancer Res; 2007 Jul; 13(13):3968-76. PubMed ID: 17606731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
    Morbidelli L; Donnini S; Chillemi F; Giachetti A; Ziche M
    Clin Cancer Res; 2003 Nov; 9(14):5358-69. PubMed ID: 14614021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.
    Scappaticci FA; Smith R; Pathak A; Schloss D; Lum B; Cao Y; Johnson F; Engleman EG; Nolan GP
    Mol Ther; 2001 Feb; 3(2):186-96. PubMed ID: 11237675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced anti-angiogenesis and anti-tumor activity of endostatin by chemical modification with polyethylene glycol and low molecular weight heparin.
    Tan H; Yang S; Liu C; Cao J; Mu G; Wang F
    Biomed Pharmacother; 2012 Dec; 66(8):648-54. PubMed ID: 23122594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic antitumor effect of antiangiogenic factor genes on colon 26 produced by low-voltage electroporation.
    Uesato M; Gunji Y; Tomonaga T; Miyazaki S; Shiratori T; Matsubara H; Kouzu T; Shimada H; Nomura F; Ochiai T
    Cancer Gene Ther; 2004 Sep; 11(9):625-32. PubMed ID: 15338011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-angiogenic activity of the purine analog 6-thioguanine.
    Presta M; Belleri M; Vacca A; Ribatti D
    Leukemia; 2002 Aug; 16(8):1490-9. PubMed ID: 12145690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with the angiogenesis inhibitor endostatin: a novel therapy in rheumatoid arthritis.
    Matsuno H; Yudoh K; Uzuki M; Nakazawa F; Sawai T; Yamaguchi N; Olsen BR; Kimura T
    J Rheumatol; 2002 May; 29(5):890-5. PubMed ID: 12022345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human myeloid and lymphoid malignancies in the non-obese diabetic/severe combined immunodeficiency mouse model: frequency of apoptotic cells in solid tumors and efficiency and speed of engraftment correlate with vascular endothelial growth factor production.
    Fusetti L; Pruneri G; Gobbi A; Rabascio C; Carboni N; Peccatori F; Martinelli G; Bertolini F
    Cancer Res; 2000 May; 60(9):2527-34. PubMed ID: 10811135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-angiogenic effects and regression of localized murine AML produced by anti-VEGF and anti-Flk-1 antibodies.
    Reichert F; Barak V; Tarshis M; Prindull G; Tarshis E; Ben-Ishay Z
    Eur J Haematol; 2005 Jul; 75(1):41-6. PubMed ID: 15946309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effect of adenovirus-mediated endostatin gene transfer on transplanted lung carcinoma in mice].
    Sui G; Xu ZF; Sun YC; Liu YJ; Wu LH; Qin X
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):93-6. PubMed ID: 18646688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition of tumor growth and metastasis via local administration of recombinant human endostatin adenovirus].
    Wu Y; Yang L; Zhao X; Su JM; Hu B; Liu JY; Niu T; Luo Y; Li Q; Wei YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):557-61. PubMed ID: 15583981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo.
    Jin X; Bookstein R; Wills K; Avanzini J; Tsai V; LaFace D; Terracina G; Shi B; Nielsen LL
    Cancer Gene Ther; 2001 Dec; 8(12):982-9. PubMed ID: 11781661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endostatin serum level in acute myeloid leukemia.
    Wrobel T; Mazur G; Kapelko K; Kuliczkowski K
    Neoplasma; 2005; 52(2):182-4. PubMed ID: 15800718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of angiogenesis inhibitors in acute myeloid leukemia.
    Fiedler W; Staib P; Kuse R; Dührsen U; Flasshove M; Cavalli F; Hossfeld DK; Berdel WE
    Cancer J; 2001; 7 Suppl 3():S129-33. PubMed ID: 11779083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.